Popular Articles

Ongoing Study Shows That Endovascular Therapy Is Associated With High Cure Rate For Childhood Eye Cancer
Expanded results of a study conducted on children with eye cancer (retinoblastoma) shows that chemotherapy delivered through endovascular (through the vessel) means not only successfully cures the cancer in a majority of cases, but achieves this cure with preserved vision. Study outcomes were presented this week at the Society of NeuroInterventional Surgery (SNIS) 6th Annual Meeting in Boca Raton, FL by lead author Pierre Gobin, Professor of Radiology in Neurosurgery and Neurology at the Weill Cornell Medical Center at New York Presbyterian Hospital in New York City.
generic viagra online
CytRx Drug Candidate INNO-206 Results In Ovarian Tumor Shrinkage In Animal Trials
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, announced that results demonstrating that its cancer drug candidate INNO-206 caused statistically significant tumor shrinkage in an animal model of ovarian cancer have been accepted for publication in the peer-reviewed journal Investigational New Drugs. The manuscript based on this animal trial, "INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model," was made available ahead of journal printing in electronic format in the January 8, 2009 on-line issue of Investigational New Drugs.
News of the day
Milestone In Live Microscopy Focus Of $2 Million NIH Grant
A proposal by a team of UC Davis scientists to develop the world"s first electron microscope capable of filming live biological processes has been awarded a $2 million grant from the National Institutes of Health.
Oncology

The Big Gamble - Will Stimulus Dollars Pay Off In Ways Health Information Consumers Can Use?

Shortly after the American Recovery and Reinvestment Act passed in February, there was a government affairs retreat of the eHealth Initiative to discuss concern regarding the $19 billion allocated for health information technology. A feature article in the June issue of the Journal of AHIMA examines conclusions policy makers made about the investment in health IT and how to engage healthcare consumers in productive use of it. Primarily, the concern is whether the stimulus investment is enough to assist the electronic health records being provided to hospitals and smaller offices, thus meeting the goal of health IT to provide more efficient, less expense, and better quality health and healthcare for consumers. The Big Gamble discusses legislative language that states one of the key purposes of ARRA is to advance the delivery of patient-centered care, and the decisions the Department of Health and Human Services will make over the next year to achieve consumer"s health information needs through several strategies: - Offer technical assistance and endorse technologies, content and best practices that facilitate proactive delivery of timely information to consumers - Conduct focus groups and structured interviews with consumers to better understand where health IT can serve their health needs - Translate medical language into understandable information with the use of text, graphics, audio and video, and - Design toolkits for consumer outreach Also discussed are the health IT provisions in ARRA that require physicians to demonstrate meaningful use of electronic health records to qualify for up to $44,000 in adoption incentives. Overall, clinicians should get credit for EHRs that provide meaningful information to consumers, therefore, if health IT tools are not helping consumers make better decisions and manage their health then the tools are not meaningfully changing healthcare. Read the complete article in the June issue of the Journal of AHIMA or online at journal.ahima.org. The American Health Information Management Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):